Mechanism of Positive Inotropic Effect of Vincanine on Cardiac Muscle Contraction Activity-Reference-Cited by-同舟云学术

Mechanism of Positive Inotropic Effect of Vincanine on Cardiac Muscle Contraction Activity

Published:2022-12-20 Issue:4 Volume:15 Page:2309-2316
ISSN:2456-2610
Container-title:Biomedical and Pharmacology Journal
language:en
Short-container-title:Biomed. Pharmacol. J.

Author:

Zhumaev Inoyat Z.¹,Boboev Sadriddin N.¹,Usmanov Pulat B.¹,Qurbonova Shakhnoza B.²,Rustamov Shavkat Yu.¹,Esimbetov Adilbay T.¹,Begdullaeva Gulnaz S.¹,A. Zaripov Abdisalim¹,M. Adizov Shahobiddin³

Affiliation:

1. 1Institute of Biophysics and Biochemistry of National University of Uzbekistan,

2. 3Tashkent state pedagogical university named after Nizami, Uzbekistan.

3. 2Institute of the Chemistry of Plant Substances, Uzbek Academy of Sciences, Tashkent, Uzbekistan.

Abstract

In the present study, the dose-dependent effect of the alkaloid vincanine on the contractile activity of rat heart papillary muscle was investigated and it was found to increase the force of muscle contraction at all concentrations. The half-maximal inotropic effect concentration (ED50) of vincanine was 21.8 μM, respectively. Studies of the effect of this alkaloid on the cardiomyocyte Na+-channel in the presence of its blocker lidocaine showed that the positive inotropic effect of vincanine does not involve the Na+-channel. When studying the effect of vincanine on Сa2+L-channels in the presence of nifedipine (IC50=0.01 μM), the positive inotropic effect of vincanine (50 μM) alkaloid was partially reduced. In general, it was found that the positive inotropic effect of vincanine on the force of papillary muscle contraction is partially mediated by Сa2+L-channels and mainly Na+/Сa2+ exchange.

Publisher

Oriental Scientific Publishing Company

Subject

Pharmacology

Reference19 articles.

1. 1. Bers D.M. Calcium Cycling and signaling in cardiac myocytes // Annu. Rev. Physiol. – 2007 – V. 7. – P. 1798-1821.

2. 2. Marks A. Ryanodine receptors in heart failure and sudden cardiac death // J. Mol. Cell. Cardiol. – 2001. – V. 33. – P. 615-624.

3. 3. Santonastasi M., Wehrens X.H. Ryanodine receptors as pharmacological targets for heart disease // Acta. Pharmacol. Sin. – 2007. – V. 28 (7). – P. 937-944.

4. 4. Bassani J.W.M., Sarcoplasmic reticulum Ca2+ release channel complex and automatism: A matter of fine tuning // Cardiovasc. Res. – 2007. – V. 75 (1). – P. 7-9.

5. 5. Bers D.M. Altered cardiac myocyte Ca2+ regulation in heart failure // Physiology. – 2006. – V. 21. – P. 380-387.